Home » CorMatrix Earns CE Mark Approval for CanGaroo
CorMatrix Earns CE Mark Approval for CanGaroo
CorMatrix Cardiovascular has won CE mark approval for its CorMatrix CanGaroo extracellular matrix envelope, the Roswell, Ga.-based company announced Tuesday.
The device is designed for use with cardiac implantable electronic devices, such as pacemakers and implantable cardioverter defibrillators.
CanGaroo nabbed FDA clearance in August 2014. — Anisa Jibrell
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May